Sj. Cleland et al., INSULIN AS A VASCULAR HORMONE - IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF CARDIOVASCULAR-DISEASE, Clinical and experimental pharmacology and physiology, 25(3-4), 1998, pp. 175-184
1. Metabolic disorders, such as obesity and non-insulin-dependent diab
etes mellitus, and cardiovascular disorders, such as essential hyperte
nsion, congestive cardiac failure and atherosclerosis, have two featur
es in common, namely relative resistance to insulin-mediated glucose u
ptake and vascular endothelial dysfunction. 2. Significant increases i
n limb blood how occur in response to systemic hyperinsulinaemia, alth
ough there is marked variation in the results due to a number of confo
unding factors, including activation of the sympathetic nervous system
. Local hyperinsulinaemia has a less marked vasodilator action despite
similar plasma concentrations, but this can be augmented by co-infusi
ng D-glucose. 3. Insulin may stimulate endothelial nitric oxide produc
tion or may act directly on vascular smooth muscle via stimulation of
the Na+-H+ exchanger and Na+/K+-ATPase, leading to hyperpolarization o
f the cell membrane and consequent closure of voltage-gated Ca2+ chann
els. 4. There is evidence both for and against the existence of a func
tional relationship between insulin-mediated glucose uptake (insulin s
ensitivity) and insulin-mediated vasodilation (which can be regarded a
s a surrogate measure for endothelial function). 5. If substrate deliv
ery is the rate-limiting step for insulin-mediated glucose uptake (in
other words, if skeletal muscle blood how is a determinant of glucose
uptake), then endothelial dysfunction, resulting in a relative inabili
ty of mediators, including insulin, to stimulate muscle blood flow, ma
y be the underlying mechanism accounting for the association of athero
sclerosis and other cardiovascular disorders with insulin resistance.
6. Glucose uptake may determine peripheral blood how via stimulation o
f ATP-dependent ion pumps with consequent vasorelaxation. 7. A 'third
factor' may cause both insulin resistance and endothelial dysfunction
in cardiovascular disease. Candidates include skeletal muscle fibre ty
pe and capillary density, distribution of adiposity and endogenous cor
ticosteroid production. 8. A complex interaction between endothelial d
ysfunction, abnormal skeletal muscle blood flow and reduced insulin-me
diated glucose uptake may be central to the link between insulin resis
tance, blood pressure, impaired glucose tolerance and the risk of card
iovascular disease. An understanding of the primary mechanisms resulti
ng in these phenotypes may reveal new therapeutic targets in metabolic
and cardiovascular disease.